ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies

Journal of Autoimmunity

Volumn 18, Issue 2, 2002, Pages 191-196

  Miao, Dongmei ^a   Yu, Liping ^a   Tiberti, Claudio ^b   Cuthbertson, David D ^c   Rewers, Marian ^a   Di Mario, Umberto ^b   Eisenbarth, George S ^a,d   Dotta, Francesco ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoantibodies; Diabetes; Epitopes; ICA512(IA 2); Radioassay

Indexed keywords

AMINO ACID; ANTIGEN; ANTIGEN ICA 512; AUTOANTIBODY; AUTOANTIGEN; EPITOPE; IMMUNOGLOBULIN FRAGMENT; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ANTIGENICITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN FAMILY; RADIOIMMUNOASSAY;

EID: 0036525525     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2001.0577     Document Type: Article

References (21)

1. Rabin D.U., Pleasic S.M., Palmer-Crocker R., Shapiro J.A. Cloning and expression of IDDM-specific human autoantigens. Diabetes. 41:1992;183-186.
2. Lan M.S., Lu J., Goto Y., Notkins A.L. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13:1994;505-514.
3. Solimena M., Dirkx R., Hermel J.-M., Pleasic-Williams S., Shapiro J.A., Caron L., Rabin D.U. ICA512, an autoantigen of type I diabetes, is an intrinsic protein of neurosecretory granules. EMBO. J. 15:1995;2102-2114.
4. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 45:1996;926-933.
5. Maclaren N., Lan M., Coutant R., Schatz D., Silverstein J., Muir A., Clare-Salzer M., She J.X., Malone J., Crockett S., Schwartz S., Quattrin T., DeSilva M., Vander V.P., Notkins A., Krischer J. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. J. Autoimmun. 12:1999;279-287.
6. Greenbaum C.J., Sears K.L., Kahn S.E., Palmer J.P. Relationship of B-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes. Diabetes. 48:1999;170-175.
7. Ziegler A.-G., Hummel M., Schenker M., Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes. The 2-year analysis of the German BABYDIAB study. Diabetes. 48:1999;460-468.
8. Colman P.G., McNair P., Margetts H., Schmidli R.S., Werther G.A., Alford F.P., Ward G.M., Tait B.D., Honeyman M.C., Harrison L.C. The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing. Med. J. Aust. 169:1998;81-84.
9. Bingley P.J., Bonifacio E., Williams A.J.K., Genovese S., Bottazzo G.F., Gale E.A.M. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 46:1997;1701-1710.
10. Gorus F.K., Goubert P., Semakula C., Vandewalle C.L., Schepper J.D., Scheen A., Christie M.R., Pipeleers D.G. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia. 40:1997;95-99.
11. Hawa M., Rowe R., Lan M.S., Notkins A.L., Pozzilli P., Christie M.R., Leslie R.D.G. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes. 46:1997;1270-1275.
12. Kawasaki E., Yu L., Rewers M.J., Hutton J.C., Eisenbarth G.S. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes. 47:1998;733-742.
13. Zhang B., Lan M.S., Notkins A.L., Lan M.S. Autoantibodies to IA-2 in IDDM: location of major antigenic determinants. Diabetes. 46:1999;40-43.
14. Kolm-Litty V., Berlo S., Bonifacio E., Bearzatto M., Engel A.M., Christie M., Ziegler A.G., Wild T., Endl J. Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen [In Process Citation]. J. Immunol. 165:2000;4676-4684.
15. Peakman M., Stevens E.J., Lohmann T., Narendran P., Dromey J., Alexander A., Tomlinson A.J., Trucco M., Gorga J.C., Chicz R.M. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4 [see comments]. J. Clin. Invest. 104:1999;1449-1457.
16. Hawkes C.J., Schloot N.C., Marks J.B., Willemen S.J., Drijfhout J.W., Mayer E.K., Christie M.R., Roep B.O. T-Cell Lines Reactive to an Immunodominant Epitope of the Tyrosine Phosphatase-Like Autoantigen IA-2 in Type 1 Diabetes. Diabetes. 49:2000;356-366.
17. Honeyman M.C., Stone N.L., Harrison L.C. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: Potential for mimcry with rotavirus and other environmental agents. Mol. Med. 4:1998;231-239.
18. Yu L., Cuthbertson D.D., Maclaren N., Jackson R., Palmer J.P., Orban T., Eisenbarth G.S., Krischer J. Expression of GAD65 and Islet Cell Antibody (ICA512) autoantibodies amongst cytoplasmic ICA+ relatives is associated with eligibility for Diabetes Prevention Trial Type-1. Diabetes. In Press.
19. Yu J., Yu L., Bugawan T.L., Erlich H.A., Barriga K., Hoffman M., Rewers M., Eisenbarth G.S. Transient anti-islet autoantibodies: infrequent occurrence and lack of association with genetic risk factors. J. Clin. Endocrinol. Metab. 85:2000;2421-2428.
20. Tiberti C., Farilla L., Yu L., Luzzago A., Carabba B., Eisenbarth G.S., DiMario U. Random peptide library: a novel approach for the identification of IA-2 autoreactive epitopes in type 1 diabetes (Abstract). Diabetologia. 43:2000.
21. Gianani R., Rabin D.U., Verge C.F., Yu L., Babu S., Pietropaolo M., Eisenbarth G.S. ICA512 autoantibody radioassay. Diabetes. 44:1995;1340-1344.